FDA APPROVED cGMP manufacture of API
Established in 2002, Wuhan Wuyao Pharmaceutical Co., Ltd. , holding subsidiary of Grand Pharmaceutical(China), is a high-tech enterprise which engaged in the API productions and sales. .
It has more than 40 products , with annual production capacity over 4,000 tons and annual sales income nearly 200 million yuan.. The products are exported to 20 countries in Asia , Europe and so on ,and the annual export value is nearly $ 40 million .What’s more ,Sodium pirenoxine and rennin are company’s exclusive products in China.
The company has been established for ten years, with the continuous development and innovation. At present, it owns a strong professional and high-tech team, which developed 7 kinds of new drugs, such as lansoprazole and etc. The company organize production in strict accordance with the GMP requirements and gain GMP certification for most products. Noradrenaline Bitartrate has been approved by U.S. Food and Drug Administration (FDA) , and Metronidazole has got EU COS certification. In 2012, the company achieved the ISO quality management system certification.
With the target of being world-renowned supplier of API and leader of domestic enterprises, company increases investment in research and expands scale of generic drugs, accelerate market and sales, promote team training, and set up professional team and independent R & D Technology Center. The company achive goal of exporting products by constructing FDA, EU certified plant, ,obtain CGMP and EUGMP certification,all these make the it more specialized, technological and international !